Our Bond executes phase 1 commercial agreement with pharmaceutical company

Our Bond (OBAI) announced the execution of a phase 1 commercial agreement valued at approximately $250,000 with one of the world’s five largest pharmaceutical companies, an organization with a market capitalization exceeding $300 billion. The agreement covers 5,000 of the customer’s 100,000 employees across various functions and locations, initially in the USA, as part of a 24/7 full workforce coverage protection concept. This establishes a new recurring revenue stream for Bond and marks the Company’s entry into a commercial relationship with a global healthcare industry leader. It also reflects further evidence that Bond is on the path to becoming a global standard of care for all employees – not only for executives – among leading global employers.